Menu
By choosing Quadropharma as your pharma partner for your products in Middle East, Africa and Europe, you will benefit from our wealth of experience in these markets. We facilitate market access to introduce your products to these regions – adhering to the highest quality and compliance standards.
Quadropharma has two core business units – Rx (prescription medicine) and consumer health. This focus is based on the specific, unmet medical need in these therapeutic areas within our region. We develop and implement successful go-to-market strategies for specialty, rare/orphan, hospital and consumer health products.
At Quadropharma, We are partnered with more than 300 manufacturers globally. We play a vital role in the API export market globally. Our commitment to quality and innovation is evident in the diverse range of Active Pharmaceutical Ingredients (APIs), which form the basis of numerous medicines. With cutting-edge facilities and a stringent adherence to international quality standards, Quadropharma has established itself as the preferred partner for pharmaceutical companies seeking high-quality APIs for their formulations.
We are looking for exclusive regional or local licensing and distribution rights for ethical pharmaceutical (Rx and OTC) and consumer health products in areas with a high, yet unmet need. We are interested in ready-to-market, finished products or innovative drug candidates in late-stage clinical development (clinical phase 3 for standard pharmaceuticals; phase 2 proof-of-concept for orphan drugs).
